Label: NEUTROGENA SKIN CLEARING BLEMISH CONCEALER - DEEP 20- salicylic acid liquid
- NDC Code(s): 69968-0338-1
- Packager: Johnson & Johnson Consumer Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated January 16, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Use
- Warnings
-
Directions
- Clean the skin thoroughly before applying this product
- Cover the entire affected area with a thin layer one to three times daily
- Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- If bothersome dryness or peeling occurs, reduce application to once a day or every other day
- Other Information
-
Inactive ingredients
Water, cyclopentasiloxane, dimethicone, kaolin, VP/hexadecene copolymer, synthetic wax, cetyl PEG/PPG-10/1 dimethicone, trisiloxane, BIS-PEG/PPG-14/14 dimethicone, cyclohexasiloxane, butylene glycol, silica, phenoxyethanol, boron nitride, polysilicone-11, quaternium-90 bentonite, sodium chloride, magnesium sulfate, methylparaben, farnesol, chamomilla recutita (matricaria) flower extract, propylene carbonate, triethoxycaprylylsilane, propylparaben, aloe barbadensis leaf juice, polymethyl methacrylate, tocopheryl acetate, cocamidopropyl PG-dimonium chloride phosphate, cetyl lactate, C12-15 alkyl lactate, benzalkonium chloride, retinyl palmitate, pantothenic acid, ascorbic acid,titanium dioxide, iron oxides
- Questions?
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 1.4 g Vial Blister Pack
-
INGREDIENTS AND APPEARANCE
NEUTROGENA SKIN CLEARING BLEMISH CONCEALER - DEEP 20
salicylic acid liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69968-0338 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 5 mg in 1 g Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) CYCLOMETHICONE 5 (UNII: 0THT5PCI0R) DIMETHICONE (UNII: 92RU3N3Y1O) KAOLIN (UNII: 24H4NWX5CO) VINYLPYRROLIDONE/HEXADECENE COPOLYMER (UNII: KFR5QEN0N9) TRISILOXANE (UNII: 9G1ZW13R0G) BIS-PEG/PPG-14/14 DIMETHICONE (UNII: X2I70H0QJE) CYCLOMETHICONE 6 (UNII: XHK3U310BA) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) PHENOXYETHANOL (UNII: HIE492ZZ3T) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) SODIUM CHLORIDE (UNII: 451W47IQ8X) MAGNESIUM SULFATE, UNSPECIFIED FORM (UNII: DE08037SAB) METHYLPARABEN (UNII: A2I8C7HI9T) FARNESOL (UNII: EB41QIU6JL) CHAMOMILE (UNII: FGL3685T2X) PROPYLENE CARBONATE (UNII: 8D08K3S51E) TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E) PROPYLPARABEN (UNII: Z8IX2SC1OH) ALOE VERA LEAF (UNII: ZY81Z83H0X) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) COCAMIDOPROPYL PROPYLENE GLYCOL-DIMONIUM CHLORIDE PHOSPHATE (UNII: H2KVQ74JM4) CETYL LACTATE (UNII: A7EVH2RK4O) C12-15 ALKYL LACTATE (UNII: GC844VRD7E) BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) PANTOTHENIC ACID (UNII: 19F5HK2737) ASCORBIC ACID (UNII: PQ6CK8PD0R) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) QUATERNIUM-90 BENTONITE (UNII: 97K5YEF88C) CETYL PEG/PPG-10/1 DIMETHICONE (HLB 5) (UNII: 035JKJ76MT) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69968-0338-1 1.4 in 1 BLISTER PACK 10/02/2017 1 1.4 g in 1 VIAL; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part333D 10/02/2017 Labeler - Johnson & Johnson Consumer Inc. (118772437)